Publications by authors named "Giovanni Bozza"

Claim this Profile
M
Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.
Rossella Hakim, Maria Cristina Salone, Giovanni Bozza, Paolo Spinnato, Alessandra Longhi

Anticancer Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review.
Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza

Diseases· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Orazio Caffo, Cinzia Ortega, Franco Nolè, Donatello Gasparro, Claudia Mucciarini, Giovanni Bozza

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Mariangela Ciccarese, Laura Orlando, Palma Fedele, Paola Schiavone, Evaristo Maiello, Giovanni Bozza

Breast J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223.
Giandomenico Roviello, Rosj Gallicchio, Giovanni Bozza, Maria Grazia Rodriquenz, Michele Aieta

Onco Targets Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib for the treatment of renal cell carcinoma.
Giandomenico Roviello, Silvia Paola Corona, Giovanni Bozza, Michele Aieta, Daniele Generali

Expert Opin Investig Drugs· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.
Giuseppina Improta, Angela Zupa, Maria Iole Natalicchio, Lorenza Sisinni, Anna Marinaccio, Giovanni Bozza

Med Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.
Alfredo Tartarone, Rosa Lerose, Maria Grazia Rodriquenz, Giuseppina Mambella, Giuseppe Calderoni, Giovanni Bozza

J Thorac Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidermal growth factor receptors as biological targets in penile cancer.
Giuseppe Di Lorenzo, Carlo Buonerba, Matteo Ferro, Giuseppe Calderoni, Giovanni Bozza

Expert Opin Biol Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival in small cell lung cancer: a case report and review of the literature.
Alfredo Tartarone, Rosa Lerose, Raffaele Ardito, Laura Troiani, Beatrice Tedesco, Giovanni Bozza

Future Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic syndrome as a peculiar target for management of prostate cancer patients.
Vincenza Conteduca, Giuseppe Di Lorenzo, Giovanni Bozza, Raffaele Ardito, Michele Aieta

Clin Genitourin Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the no-sampling linear sampling method to breast cancer detection.
Giovanni Bozza, Massimo Brignone, Matteo Pastorino

IEEE Trans Biomed Eng· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis